Belviq is a pharmaceutical company that has recently released an anti-obesity drug. The FDA’s decision to approve the medication puts it in direct competition with other types of weight loss supplements and their efficacy as well as long term side effects are still unknown.
Belviq is a weight loss drug that was approved by the FDA in 2015. The drug has been removed from the market due to serious side effects, including heart problems and liver damage.
Belviq is a weight-loss medicine that was formerly made by Arena Pharmaceuticals in Switzerland before being bought by Eisai Inc. in January 2017. Belviq was manufactured and marketed by Eisai until February 2020, when it was withdrawn from the worldwide market due to findings that it may raise cancer risk.
Belviq was authorized by the US Food and Drug Administration (FDA) on June 27, 2012, for use in obese and overweight people with a comorbid disease, such as type 2 diabetes or hypertension, as a supplement to diet and exercise. The medicine was released the next year, however it was not well received by customers.
Belviq XR, a once-daily, slow-release form of Belviq, was authorized by the FDA in July 2016. Eisai Inc., which had been the drug’s marketing partner, bought it from Arena Pharmaceuticals for $23 million six months later. For the 2017 fiscal year, Eisai reported $31.5 million in Belviq sales in the United States and $42.2 million in Japan.
In the summer of 2018, a study of 12,000 individuals found that those who took Belviq had no elevated cardiovascular risk. However, the FDA revealed in January 2020 that it was looking into a potential relationship between Belviq and cancer. The following month, the FDA announced that the same research of 12,000 patients had shown that those who took Belviq had a greater risk of cancer (as opposed to a placebo). The FDA ordered a complete recall of all Belviq and Belviq XR products, which Eisai cooperated with. Eisai is removing the medicine off store shelves all across the globe.
Please contact us for a free, no-risk case assessment if you or a loved one has been diagnosed with cancer after using Belviq. A Belviq lawsuit might help you be compensated.
What is the Process of Belviq?
Belviq stimulates the brain’s serotonin 2c receptor. As a consequence, a person may feel more satisfied after consuming less food, resulting in weight reduction (when paired with exercise and dietary changes).
Those who took Belviq for up to a year lost 3 to 3.7 percent more weight on average, according to a study of 8,000 overweight and obese individuals.
What Are the Approved Applications of Belviq?
Belviq has been taken off the market, however it was authorized for use as a supplement to diet and exercise for obese adults and overweight adults with a comorbid disease from June 2012 to January 2020. (e.g., type 2 diabetes, hypertension).
What Are the Side Effects of Belviq?
Belviq may cause the following adverse effects in addition to allergic responses (hives; trouble breathing; swelling of the face, mouth, or throat):
- Mouth or eyes that are dry
- Back ache
- Swings in mood
- Suicidal ideation
- Vision is hazy
- Problems with memory and focus
- Increased heart rate
- Breasts swollen
- The discharge of nipples
- Having the sensation of being outside of your body
Why was Belviq recalled by the FDA?
A five-year, double-blind trial of 12,000 patients indicated that those using Belviq had a higher cancer rate. “A variety of cancer types were recorded,” according to the FDA, “with multiple distinct kinds of malignancies occurring more often in the lorcaserin group, including pancreatic, colorectal, and lung cancers.”
Who is eligible to file a Belviq lawsuit?
People who took Belviq and were later diagnosed with cancer may be eligible for reimbursement for medical expenses, pain and suffering, lost income, and other damages. They should contact a personal injury lawyer who may be able to assist them in recovering the money they are entitled.
Because many claims are time-sensitive, aggrieved customers should contact an attorney as soon as feasible.
Belviq is a prescription weight-loss medication that was approved by the FDA in 2014. The drug is an extended release form of phentermine, which is used to treat obesity and has been known to help with weight loss. Reference: belviq xr.
Frequently Asked Questions
Why was Belviq discontinued?
A: Belviq was discontinued because of the false advertising claims about weight loss.
What kind of cancer does Belviq cause?
A: The side effects of Belviq are non-specific to any particular cancer. However, the drug is primarily used for treating depression and anxiety disorders.
Was Belviq discontinued?
A: Yes, Belviq is discontinued.
- belviq used for
- belviq dosage
- belviq price
- belviq side effects
- belviq reviews